Treating ocular myasthenia gravis with inadequate evidence

Archives of Neurology

Volumn 64, Issue 12, 2007, Pages 1794-1795

  Roach, E S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; CORTICOSTEROID DERIVATIVE;

ARTICLE; DIPLOPIA; DISEASE COURSE; HUMAN; IMMUNOTHERAPY; LONG TERM CARE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PTOSIS; REMISSION; THYMECTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

COMBINED MODALITY THERAPY; EYE DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; PREDNISONE; THYMECTOMY;

EID: 37149018763     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.12.1794     Document Type: Article

References (2)

1. Gilbert ME, De Sousa EA, Savino PJ. Ocular myasthenia gravis treatment: the case against prednisone therapy and thymectomy. Arch Neurol. 2007;64(12):1790-1792.
2. Chavis PS, Stickler DE, Walker A. Immunosuppressive or surgical treatment for ocular myasthenia gravis. Arch Neurol. 2007;64(12):1792-1794.